Orbotech Ltd. today announced the introduction of its new Paragon™-Xpress 9 Laser Direct Imaging (LDI) system.

Designed for high speed throughput of up to 5,000 panels a day per in-line solution, Paragon-Xpress 9 is a breakthrough LDI system for mass production digital imaging of HDI, flex and rigid-flex applications. Featuring the same Large Scan Optics (LSO) Technology™ as Orbotech's well-established Paragon LDI family for highest imaging accuracy, the automated Paragon-Xpress 9 is now able to improve yields and productivity on the most advanced volume jobs--faster and more cost-effectively than ever before.

"Our latest technology advancements in Paragon-Xpress 9 focus on boosting Paragon LDI performance to meet high volume speed requirements. The system has already been field-proven in rigorous mass production environments with excellent results," said Hanan Gino, President of the PCB Division at Orbotech Ltd. "Being able to reach these throughput levels without having to compromise on quality represents a crucial milestone in the progress of modern PCB digital imaging. It has now opened the door to the widespread utilization of LDI for HDI mass production."

About Orbotech Ltd.

Orbotech is principally engaged in the design, development, manufacture, marketing and service of yield-enhancing and production solutions for specialized applications in the supply chain of the electronics industry. Orbotech's products include AOI, production and process control systems for PCBs and AOI, test and repair systems for flat panel displays (FPDs).  The company also markets computer-aided manufacturing and engineering (CAM) solutions for PCB production. 

In addition, through its subsidiary, Orbograph Ltd., the company develops and markets character recognition solutions to banks and other financial institutions, and has developed a proprietary technology for Web-based, location-independent data entry for check processing and forms processing; and, through its subsidiaries, Orbotech Medical Denmark A/S and Orbotech Medical Solutions Ltd., is engaged in the research and development, manufacture and sale of specialized products for application in medical nuclear imaging. 

Of Orbotech's employees, more than one quarter are scientists and engineers, who integrate their multi-disciplinary knowledge, talents and skills to develop and provide sophisticated solutions and technologies designed to meet customers' long-term needs.  Orbotech maintains its headquarters and its primary research, development and manufacturing facilities in Israel, and more than 30 offices worldwide. Orbotech's extensive network of marketing, sales and customer support teams throughout North America, Europe, the Pacific Rim, China and Japan deliver its knowledge and expertise directly to customers the world over. For more information, visit www.orbotech.com.